Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

Proinflammatory cytokine changes in clinically stable, virologically suppressed, HIV-infected patients switching from protease inhibitors to abacavir.

Virgili N, Fisac C, Martínez E, Ribera E, Gatell JM, Podzamczer D.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):552-3. doi: 10.1097/QAI.0b013e318198a21a. No abstract available.

PMID:
19300101
2.

Switching strategies to improve lipid profile and morphologic changes.

Barragan P, Fisac C, Podzamczer D.

AIDS Rev. 2006 Oct-Dec;8(4):191-203. Review.

PMID:
17219734
3.

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study.

Podzamczer D, Ferrer E, Sanchez P, Gatell JM, Crespo M, Fisac C, Lonca M, Sanz J, Niubo J, Veloso S, Llibre JM, Barrufet P, Ribas MA, Merino E, Ribera E, Martínez-Lacasa J, Alonso C, Aranda M, Pulido F, Berenguer J, Delegido A, Pedreira JD, Lérida A, Rubio R, del Río L; ABCDE (Abacavir vs. d4T (stavudine) plus efavirenz) Study Team.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):139-47.

PMID:
17106274
4.

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine.

Fisac C, Fumero E, Crespo M, Roson B, Ferrer E, Virgili N, Ribera E, Gatell JM, Podzamczer D.

AIDS. 2005 Jun 10;19(9):917-25.

PMID:
15905672
5.

Orotic aciduria and plasma urea cycle-related amino acid alterations in short bowel syndrome, evoked by an arginine-free diet.

Pita AM, Fernandez-Bustos A, Rodes M, Arranz JA, Fisac C, Virgili N, Soler J, Wakabayashi Y.

JPEN J Parenter Enteral Nutr. 2004 Sep-Oct;28(5):315-23.

PMID:
15449570
6.

A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled study.

Fisac C, Virgili N, Ferrer E, Barbera MJ, Fumero E, Vilarasau C, Podzamczer D.

J Clin Endocrinol Metab. 2003 Nov;88(11):5186-92.

PMID:
14602748
Items per page

Supplemental Content

Loading ...
Write to the Help Desk